Experiment 66643
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | RUHNAUT,KJ: MEISSNERT,HP: FINN,JR: RELJANOVIC,M: LOBISCH,M: SCHUTTE,K: NEHRDICH,D: TRITSCHLER,HJ: MEHNERT,H: ZIEGLER,D:. (1999). EFFECTS OF 3-WEEK ORAL TREATMENT WITH THE ANTIOXIDANT THIOCTIC ACID (ALPHA-LIPOIC ACID) IN SYMPTOMATIC DIABETIC POLYNEUROPATHY.. 16(12) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED EFFICACY OF THIOCTIC ACID(TA) ON NEUROPATHIC SYMPTOMS AND DEFICITS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WAS DETERMINED. THE TOTAL SYMPTOM SCORE(TSS) IN THE FOOT DECREASED FROM BASELINT TO DAY 19 BY -47% AND -24% IN PLACEBO. THE NEUROPATHY DISABILITY SCORE(NDS) DECREASED AND IT WAS P=0.025 FOR TESTED GROUP VS. PLACEBO). RESULTS INDICATE THAT THIOCTIC ACID MAY IMPROVE SYMPTOMS RESULTING FROM POLYNEUROPATHY IN TYPE 2 DIABETIC PATIENTS. |
| Dose amount | 1.80 GM |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |